3.0.0 7166 2022-12-29T22:03:48Z 2022-12-29T22:03:48Z House HR 2022-03-18 117 [Congressional Record Volume 168, Number 49 (Friday, March 18, 2022)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. MOONEY:H.R. 7166.Congress has the power to enact this legislation pursuantto the following:Article I, Section 1 provides that ``All legislative Powersherein granted shall be vested in a Congress of the UnitedStates, which shall consist of a Senate and a House ofRepresentatives.''Article I, Section 5, Clause 2 provides that each house ofCongress ``may determine the Rules of its Proceedings.''[Page H3854]]]> hswm00 Ways and Means Committee House Standing Referred to 2022-03-18T13:00:35Z 2022-03-18 Referred to the House Committee on Ways and Means. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2022-03-18 Introduced in House IntroReferral Intro-H 9 Library of Congress 2022-03-18 Introduced in House IntroReferral 1000 9 Library of Congress M001195 Rep. Mooney, Alexander X. [R-WV-2] Alexander Mooney R WV X. 2 N T000483 Rep. Trone, David J. [D-MD-6] David Trone D MD J. 6 2022-05-19 False Taxation Taxation 00 2022-03-18 Introduced in House 2022-03-23T14:52:39Z Make Medicine in America Again Act

This bill provides tax incentives for the manufacture of pharmaceutical property, equipment, buildings, or facilities in the United States. Specifically it allows bonus depreciation for such property and a business-related tax credit for 50% of expenditures for (1) wages for services performed in a U.S. pharmaceutical manufacturing business, (2) the tangible personal property of such a business, and (3) any direct or indirect costs paid or incurred in a U.S. pharmaceutical manufacturing business.

]]> Make Medicine in America Again Act Display Title Make Medicine in America Again Act Short Title(s) as Introduced Make Medicine in America Again Act Introduced in House IH Official Title as Introduced To amend the Internal Revenue Code of 1986 to provide for extended expensing of pharmaceutical manufacturing property, and for other purposes. Introduced in House IH Introduced in House 2022-03-18T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-117hr7166ih/xml/BILLS-117hr7166ih.xml 2022-03-18 Referred to the House Committee on Ways and Means. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.